EuroPharma

NCT04918667

Phase 1, Not yet recruiting, 2024, 16 people, 9 Jun 2021, clinicaltrials.gov

NCT03947554

Phase 1/2, Completed, 2019, 50 people, 13 May 2019, clinicaltrials.gov

NCT02978339

Collaborator, Phase 1/2, Completed, 2017, 15 people, 30 Nov 2016, clinicaltrials.gov